ClinicalTrials.Veeva

Menu

Morphine and/or Nalbuphine as Adjuvants in Ultrasound Guided Interscalene Block: for Shoulder Surgeries

A

Assiut University

Status and phase

Unknown
Phase 2

Conditions

Rotator Cuff Tear

Treatments

Drug: Bupivacaine 0.5%
Drug: Lidocaine Hydrochloride 1% and epinephrine 1:400,000
Drug: Nalbuphine
Drug: Morphine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

the aim of this study is to evaluate the duration of analgesia when either morphine or nalbuphine or both are used as adjuvants in sonar guided interscalene brachial plexus block for arthroscopic rotator cuff repair.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients scheduled for arthroscopic repair of rotator cuff muscle tear of the shoulder.
  • ASA physical status I - Ш.

Exclusion criteria

  • Infection at the site of injection.
  • Coagulopathy or other bleeding diathesis.
  • Known allergy to drugs in the study
  • Preexisting neurologic deficits in the area to be blocked.
  • Inability to communicate with the investigator and the hospital staff.
  • History of chronic opioid use.
  • Morbid obesity BMI>40.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 4 patient groups, including a placebo group

Morphine
Experimental group
Description:
5 mg morphine in 5ml volume injected as adjuvants to 10 ml of lidocaine and epinephrine 1:400,000.
Treatment:
Drug: Morphine
Drug: Lidocaine Hydrochloride 1% and epinephrine 1:400,000
Nalbuphine
Experimental group
Description:
5 mg nalbuphine in 5ml volume injected as adjuvants to 10 ml of lidocaine and epinephrine 1:400,000.
Treatment:
Drug: Nalbuphine
Drug: Lidocaine Hydrochloride 1% and epinephrine 1:400,000
Morphine and Nalbuphine
Experimental group
Description:
5 mg morphine and 5 mg nalbuphine in 5 ml volume are injected as adjuvants to 10 ml of lidocaine and epinephrine 1:400,000. combination of 5 mg morphine and 5 mg nalbuphine in 5 ml volume are injected perineurally as adjuvants for 10 ml of lidocaine + epinephrine 1:400,000 in ultrasound guided interscalene block
Treatment:
Drug: Nalbuphine
Drug: Morphine
Drug: Lidocaine Hydrochloride 1% and epinephrine 1:400,000
Bupivacaine 0.5%
Placebo Comparator group
Description:
10 ml of lidocaine 1% and epinephrine 1:400,000 and 5 ml of Bupivacaine 0.5% in interscalene block.
Treatment:
Drug: Lidocaine Hydrochloride 1% and epinephrine 1:400,000
Drug: Bupivacaine 0.5%

Trial contacts and locations

1

Loading...

Central trial contact

Shimaa A Husien, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems